相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genomic profiling of a randomized trial of interferon-a vs hydroxyurea in MPN reveals mutation-specific responses
Trine Alma Knudsen et al.
BLOOD ADVANCES (2022)
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
Benjamin A. H. Smith et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Zinc-dependent multimerization of mutant calreticulin is required for MPL binding and MPN pathogenesis
Jeanne F. Rivera et al.
BLOOD ADVANCES (2021)
Mutant calreticulin interacts with MPL in the secretion pathway for activation on the cell surface
Nami Masubuchi et al.
LEUKEMIA (2020)
The stem/progenitor landscape is reshaped in a mouse model of essential thrombocythemia and causes excess megakaryocyte production
Daniel Prins et al.
SCIENCE ADVANCES (2020)
Calreticulin mutants as oncogenic rogue chaperones for TpoR and traffic-defective pathogenic TpoR mutants
Christian Pecquet et al.
BLOOD (2019)
Prevalence and phenotypes of JAK2 V617F and calreticulin mutations in a Danish general population
Sabrina Cordua et al.
BLOOD (2019)
Somatic mutations and cell identity linked by Genotyping of Transcriptomes
Anna S. Nam et al.
NATURE (2019)
Mutant calreticulin knockin mice develop thrombocytosis and myelofibrosis without a stemcell self-renewal advantage
Juan Li et al.
BLOOD (2018)
Defining the requirements for the pathogenic interaction between mutant calreticulin and MPL in MPN
Shannon Elf et al.
BLOOD (2018)
Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants
Ilyas Chachoua et al.
BLOOD (2016)
Ruxolitinib is an effective treatment for CALR-positive patients with myelofibrosis
Paola Guglielmelli et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms
D. Pietra et al.
LEUKEMIA (2016)
Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms
Marito Araki et al.
BLOOD (2016)
Calreticulin-mutant proteins induce megakaryocytic signaling to transform hematopoietic cells and undergo accelerated degradation and Golgi-mediated secretion
Lijuan Han et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Thrombopoietin receptor is required for the oncogenic function of CALR mutants
H. Nivarthi et al.
LEUKEMIA (2016)
Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation
Shannon Elf et al.
CANCER DISCOVERY (2016)
Single Targeted Exon Mutation Creates a True Congenic Mouse for Competitive Hematopoietic Stem Cell Transplantation: The C57BL/6-CD45.1STEM Mouse
Francois E. Mercier et al.
STEM CELL REPORTS (2016)
The JAK-STAT signaling pathway is differentially activated in CALR-positive compared with JAK2V617F-positive ET patients
Winnie W. Y. Lau et al.
BLOOD (2015)
Antileukemic Activity of 2-Deoxy-D-Glucose through Inhibition of N-Linked Glycosylation in Acute Myeloid Leukemia with FLT3-ITD or c-KIT Mutations
Clement Larrue et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Improved vectors and genome-wide libraries for CRISPR screening
Neville E. Sanjana et al.
NATURE METHODS (2014)
A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors
Luis E. Raez et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
J. Nangalia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
Thorsten Klampfl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Extracellular Domain N-Glycosylation Controls Human Thrombopoietin Receptor Cell Surface Levels
Roxana I. Albu et al.
Frontiers in Endocrinology (2011)
Deficiency of Dol-P-Man Synthase Subunit DPM3 Bridges the Congenital Disorders of Glycosylation with the Dystroglycanopathies
Dirk J. Lefeber et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2009)
Dolichol-phosphate mannose synthase: Structure, function and regulation
Yusuke Maeda et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2008)
The Warburg effect and its cancer therapeutic implications
Zhao Chen et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2007)
Human dolichol-phosphate-mannose synthase consists of three subunits, DPM1, DPM2 and DPM3
Y Maeda et al.
EMBO JOURNAL (2000)
Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie
T Imbach et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
分享论文
